N/A N=72 Randomized Single-blind Diagnostic

Trial Comparing 19 and 25-gauge EUS-FNA Needles

Cancer of Pancreas · Pancreatic Neoplasm

Bottom Line

View on ClinicalTrials.gov: NCT01677312 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2020

Primary outcome: Primary: Median Number of Passes to Establish Diagnosis — 1; 1 No. of passes

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Pancreatic Biopsy (Procedure); Histological Samples (Procedure)
Age: Adult, Older Adult · 19+ yrs
Sex: All
Sponsor: AdventHealth
Primary completion: Jan 2013

Outcome Measures

Outcome	Result	p-value
PRIMARY Median Number of Passes to Establish Diagnosis	1; 1	—
SECONDARY Procurement of Histological Samples	86.1; 33.3	—
SECONDARY Needle Dysfunction	0; 2.8	—
SECONDARY Complications	2.8; 0	—

Summary

This study compares the 19G and 25G needles for procuring tissue samples from the pancreas during Endoscopic Ultrasound (EUS) procedures.

Eligibility Criteria

INCLUSION CRITERIA

(1) Patients with solid pancreatic mass lesions.

EXCLUSION CRITERIA

Age 1.6, Prothrombin Time > 18secs, Thrombocytopenia < 80,000 cells/ml)
Unable to consent
Non-English speaking patients

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01677312). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.